These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1384335)

  • 41. Experience with midtrimester abortion.
    Pahl IR; Lundy LE
    Obstet Gynecol; 1979 May; 53(5):587-91. PubMed ID: 440670
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486).
    el-Refaey H; Hinshaw K; Templeton A
    Hum Reprod; 1993 Oct; 8(10):1744-6. PubMed ID: 8300840
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dinoprostone (Prostin E2): a prostaglandin for clinical use in obstetrics and gynaecology.
    Turnbull AC
    Prescr J; 1973 Apr; 13(2):25-31. PubMed ID: 12262441
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparative study of two types of prostaglandins for abortion during the second trimester.
    Rettenmaier MA; Hanson FW
    Surg Gynecol Obstet; 1983 May; 156(5):585-8. PubMed ID: 6573807
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of ethacridine lactate and prostaglandin E2 in second trimester medical abortion.
    Inan I; Kelekçi S; Yazar D
    Acta Obstet Gynecol Scand; 1997 Aug; 76(7):680-3. PubMed ID: 9292644
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Medical methods for first trimester abortion.
    Kulier R; Gülmezoglu AM; Hofmeyr GJ; Cheng LN; Campana A
    Cochrane Database Syst Rev; 2004; (1):CD002855. PubMed ID: 14973995
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prostaglandin E2 vaginal suppository as a midtrimester abortifacient.
    Bolognese RJ; Corson SL
    Am J Obstet Gynecol; 1974 Sep; 120(2):281-4. PubMed ID: 4415348
    [No Abstract]   [Full Text] [Related]  

  • 48. The contribution of laminaria placement for cervical ripening in second trimester termination of pregnancy induced by intra-amniotic injection of prostaglandin F(2)alpha followed by concentrated oxytocin infusion.
    Almog B; Levin I; Winkler N; Fainaru O; Pauzner D; Lessing JB; Gamzu R
    Eur J Obstet Gynecol Reprod Biol; 2005 Jan; 118(1):32-5. PubMed ID: 15596269
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Termination of second trimester pregnancy by intramuscular injection of 16-phenoxy-omega-17,18,19,20-tetranor-PGE2 methyl sulphonylamide.
    Int J Gynaecol Obstet; 1982 Oct; 20(5):383-6. PubMed ID: 6128270
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mid-trimester termination of pregnancy--a randomised controlled trial of two prostaglandin regimens.
    Steyn DW; Pienaar MP
    S Afr Med J; 1993 Oct; 83(10):737-8. PubMed ID: 8191328
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Laminaria use in midtrimester abortions induced by intra-amniotic prostaglandin F2alpha with urea and intravenous oxytocin.
    Strauss JH; Wilson M; Caldwell D; Otterson W; Martin AO
    Am J Obstet Gynecol; 1979 Jun; 134(3):260-4. PubMed ID: 453259
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mid-trimester abortion using hypertonic saline or prostaglandin E2 gel: an analysis of efficacy and complications.
    Herabutya Y; O-Prasertsawat P
    J Med Assoc Thai; 1994 Mar; 77(3):148-52. PubMed ID: 7798849
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The management of midtrimester abortion failures by vaginal evacuation.
    Burkman RT; Atienza MF; King TM; Burnett LS
    Obstet Gynecol; 1977 Feb; 49(2):233-6. PubMed ID: 834407
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of intra-amniotic urea as a second trimester abortifacient.
    Khare A; Deshmukh MA; Vaidya PR; Sayed A; Companywalla RT; Motashaw ND
    J Postgrad Med; 1979 Jul; 25(3):158-61. PubMed ID: 529168
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Extra-amniotic prostaglandin E2 and intravenous oxytocin in termination of mid-trimester pregnancy and the management of missed abortion and hydatiform mole.
    Arshat H
    Med J Malaysia; 1977 Mar; 31(3):220-5. PubMed ID: 904515
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multiple-dose vaginal misoprostol and single-dose misoprostol plus oxytocin for termination of second-trimester pregnancy.
    Zangeneh M; Malek-Khosravi S; Veisi F; Rezavand N; Rezaee M; Rajatee M
    Int J Gynaecol Obstet; 2012 Apr; 117(1):78-80. PubMed ID: 22261129
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Midtrimester pregnancy termination--contemporary methods and techniques. Review].
    Andreeva A; Marinov B
    Akush Ginekol (Sofiia); 2011; 50(4):35-41. PubMed ID: 22479895
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Premature termination of pregnancy in the 2nd and 3rd trimester. Serial administration of 1 mg gemeprost vaginal suppositories versus intravenous sulproston].
    Müller T; Backe J; Rempen A
    Geburtshilfe Frauenheilkd; 1996 May; 56(5):234-8. PubMed ID: 8768060
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of failed prostaglandin abortions.
    Lauersen NH; Wilson KH; Zervoudakis IA; Saary Z
    Obstet Gynecol; 1976 Apr; 47(4):473-8. PubMed ID: 943738
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HCG, progesterone and 17-beta-estradiol levels during extra-amniotically induced early abortion by a new prostaglandin derivative (Sulprostone).
    Nilsson S; Zador G; Nygren KG; Wide L
    Gynecol Obstet Invest; 1981; 12(4):203-10. PubMed ID: 7250783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.